Literature DB >> 27476113

SOX-mediated molecular crosstalk during the progression of tumorigenesis.

Ya-Ru Xu1, Wan-Xi Yang2.   

Abstract

SOX family transcription factor has emerged as a double-edged sword relating to tumorigenesis and metastasis. Multiple studies have revealed different expression patterns and contradictory roles of SOX factors in the tumor initiation and progression. The aberrant expression of SOX factors is regulated by copy number alteration, methylation modulation, microRNAs, transcription factors and post-translational modification. This review summarizes the role of SOX factors in molecular interactions and signaling pathways during different steps of carcinogenesis, such as CSCs stemness maintenance, EMT occurrence, cell invasion, cell proliferation and apoptosis. The Wnt signaling pathway is also shown to provide vital intermediate signaling transduction. We believe that SOX family proteins may be used as prognostic markers for human clinical therapy, and novel therapy strategies targeting SOX factors should be explored in future clinical applications.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell cycle; SOX; Stemness; Tumorigenesis; Wnt pathway; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27476113     DOI: 10.1016/j.semcdb.2016.07.028

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  15 in total

Review 1.  Regulation of fibroblast-like synoviocyte transformation by transcription factors in arthritic diseases.

Authors:  Pallavi Bhattaram; Kyle Jones
Journal:  Biochem Pharmacol       Date:  2019-03-13       Impact factor: 5.858

2.  SOX13 regulates cancer stem-like properties and tumorigenicity in hepatocellular carcinoma cells.

Authors:  Hui Jiao; Fei Fang; Ting Fang; Yuting You; Min Feng; Xiaomin Wang; Zhenyu Yin; Wenxiu Zhao
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

3.  The oncogenic role of SOX8 in endometrial carcinoma.

Authors:  Wenyan Tian; Zhanghuan Li; Lu Bai; Lingli Chen; Ye Yan; Huihui Li; Yanyan Han; Fei Teng; Chao Gao; Fengxia Xue; Yingmei Wang
Journal:  Cancer Biol Ther       Date:  2020-11-16       Impact factor: 4.742

4.  The MyoD family inhibitor domain-containing protein enhances the chemoresistance of cancer stem cells in the epithelial state by increasing β-catenin activity.

Authors:  Chao-Ju Chen; Chih-Jen Yang; Sheau-Fang Yang; Ming-Shyang Huang; Yu-Peng Liu
Journal:  Oncogene       Date:  2020-01-07       Impact factor: 9.867

5.  SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.

Authors:  Xianglin Hao; Fei Han; Bangjin Ma; Ning Zhang; Hongqiang Chen; Xiao Jiang; Li Yin; Wenbin Liu; Lin Ao; Jia Cao; Jinyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2018-05-31

6.  SOX15 regulates proliferation and migration of endometrial cancer cells.

Authors:  Xiaohui Rui; Yun Xu; Xiping Jiang; Caixia Guo; Jingting Jiang
Journal:  Biosci Rep       Date:  2017-10-17       Impact factor: 3.840

7.  Identification of HMG-box family establishes the significance of SOX6 in the malignant progression of glioblastoma.

Authors:  Lan Jiang; Hui Yang; Tianbing Chen; Xiaolong Zhu; Jingjing Ye; Kun Lv
Journal:  Aging (Albany NY)       Date:  2020-05-10       Impact factor: 5.682

8.  High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma.

Authors:  Shuwei Chen; Huan Li; Xiyuan Li; Wenkuan Chen; Xing Zhang; Zhongyuan Yang; Zhipeng Chen; Jingtao Chen; Ying Zhang; Dingbo Shi; Ming Song
Journal:  Cancer Med       Date:  2020-04-19       Impact factor: 4.452

9.  Extract of Spatholobus suberctus Dunn ameliorates ischemia-induced injury by targeting miR-494.

Authors:  Shiqing Song; Faliang Lin; Pengyan Zhu; Changyan Wu; Shuling Zhao; Qiao Han; Xiaomei Li
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

10.  SOX5 induces lung adenocarcinoma angiogenesis by inducing the expression of VEGF through STAT3 signaling.

Authors:  Xin Chen; Qi Zheng; Weidong Li; Yuan Lu; Yiming Ni; Liang Ma; Yufei Fu
Journal:  Onco Targets Ther       Date:  2018-09-11       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.